BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33150391)

  • 1. Serum and Urine Protein Electrophoresis and Serum-Free Light Chain Assays in the Diagnosis and Monitoring of Monoclonal Gammopathies.
    Singh G
    J Appl Lab Med; 2020 Nov; 5(6):1358-1371. PubMed ID: 33150391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
    Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
    Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Free Light Chain Assay and κ/λ Ratio Performance in Patients Without Monoclonal Gammopathies:  High False-Positive Rate.
    Singh G
    Am J Clin Pathol; 2016 Aug; 146(2):207-14. PubMed ID: 27473738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of Free Immunoglobulin Light Chains in Urine.
    Singh G; Cotter T; Ye Mon M; Xu H; Bollag RJ
    J Appl Lab Med; 2023 Nov; 8(6):1101-1114. PubMed ID: 37725944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine Protein Immunofixation Electrophoresis: Free Light Chain Urine Immunofixation Electrophoresis Is More Sensitive than Conventional Assays for Detecting Monoclonal Light Chains and Could Serve as a Marker of Minimal Residual Disease.
    Singh G; Arinze N; Manthei DM; Plapp FV; Bollag RJ
    Lab Med; 2023 Sep; 54(5):527-533. PubMed ID: 36857478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
    Wood PB; McElroy YG; Stone MJ
    Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Free Light Chain Assay in Monoclonal Gammopathic Manifestations.
    Lee WS; Singh G
    Lab Med; 2019 Oct; 50(4):381-389. PubMed ID: 30957173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Free Light Chain Assay and κ/λ Ratio: Performance in Patients With Monoclonal Gammopathy-High False Negative Rate for κ/λ Ratio.
    Singh G
    J Clin Med Res; 2017 Jan; 9(1):46-57. PubMed ID: 27924175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification by Ultrafiltration and Immunofixation Electrophoresis Testing for Monoclonal Serum Free Light Chains.
    Singh G; Bollag R
    Lab Med; 2020 Nov; 51(6):592-600. PubMed ID: 32285117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
    Cao F; Zhang R; Xu L; Liu M; Yuan Y
    Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the efficiency of free light chain assay in monitoring patients with multiple myeloma before and after autologous stem cell transplantation along with serum protein electrophoresis and serum protein immunofixation.
    Dogaru M; Lazăr V; Coriu D
    Roum Arch Microbiol Immunol; 2011; 70(1):15-22. PubMed ID: 21717807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies.
    Lee WS; Singh G
    J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and Diagnosis of Monoclonal Gammopathies: An International Survey of Laboratory Practice.
    Genzen JR; Murray DL; Abel G; Meng QH; Baltaro RJ; Rhoads DD; Delgado JC; Souers RJ; Bashleben C; Keren DF; Ansari MQ
    Arch Pathol Lab Med; 2018 Apr; 142(4):507-515. PubMed ID: 29266967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of serum free light chain testing for the diagnosis and monitoring of monoclonal gammopathies in hematology.
    Jagannath S
    Clin Lymphoma Myeloma; 2007 Sep; 7(8):518-23. PubMed ID: 18021469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
    Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
    Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laboratory testing for monoclonal gammopathies: Focus on monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Willrich MAV; Murray DL; Kyle RA
    Clin Biochem; 2018 Jan; 51():38-47. PubMed ID: 28479151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum Free Light Chain Quantification Testing: Comparison of Two Methods for Disease Monitoring.
    Singh G; Whitaker BM; Wu AHB; Xu H; Bollag RJ
    J Appl Lab Med; 2022 Oct; 7(6):1290-1301. PubMed ID: 36006797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.